【GC Life Sciences-KY】April 2026 Revenue 42 Million NTD (YoY +31.2%)
GC Life Sciences-KY (6431) announced April 2026 revenue of 42 million NTD, showing significant year-over-year growth of 31.2%. This notable increase in the biotechnology and medical sector highlights the company's strong market momentum.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 11:27 (3h 27m after Collected)
GC Life Sciences Co., Ltd. (KY) (Stock Code: 6431), a participant in the biotechnology and medical industry, has released its revenue results for April 2026. The company reported a monthly revenue of 41.697 million NTD (approximately 0.42 hundred million NTD). This figure represents a substantial year-over-year growth of 31.2%, indicating strong business expansion and positive market reception within the healthcare sector.